DOJ Throws Lifeline To J&J At 3rd Circ. After $1.6B FCA Loss
By Jeff Overley · August 27, 2025, 11:20 PM EDT
A district judge made multiple errors in an opinion and jury instructions underpinning a staggering False Claims Act verdict tied to Johnson & Johnson's drug marketing practices, and a fresh look...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login